Clinical importance of microvessel density, p53 and bcl-2 protein expression in breast cancer

被引:0
|
作者
Osaki, A
Kuroi, K
Murakami, S
Toge, T
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
To determine the absolute and relative value of microvessel density (MVD). p53 and bcl-2 protein expression, conventional prognosticators in predicting relapse-free survival rate (RFS) and overall survival rate (OS) in breast cancer patients We monitored 47 consecutive breast cancer patients with stage I, II, or III disease ( median follow-up period: 104 months). Univariate analyses showed that MVD (P=0.064) and p53 protein (P=0.058) were borderline significant prognosticators of RFS. Nodal status(n) (P=0.003) and lymphatic invasion (ly) (P=0.022) were significantly associated with RFS. n (P=0.03) and ly (P=0.037) were significantly related with OS. Multivariate analysis showed that n was only independent predictor for RFS. MVD, p53 and bcl-2 expression did not show an independent power to predict OS. However, it is possible that MV D and p53 expression may be a second predictor to RFS.
引用
收藏
页码:1513 / 1516
页数:4
相关论文
共 50 条
  • [21] Prognostic significance of Bcl-2 and p53 expression in gastric cancer
    Hyeon Kook Lee
    Hye Seung Lee
    Han-Kwang Yang
    Woo Ho Kim
    Kuhn Uk Lee
    Kuk Jin Choe
    Jin-Pok Kim
    International Journal of Colorectal Disease, 2003, 18 : 518 - 525
  • [22] Prognostic value of apoptosis and survivin, bcl-2, p53 expression in breast cancer patients
    Kim, S. Y.
    Woo, H. D.
    Sohn, D. M.
    Lim, C. W.
    Lee, M. H.
    BREAST, 2007, 16 : S26 - S26
  • [23] Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancer
    Perrone, G
    Vincenzi, B
    Santini, D
    Verzì, A
    Tonini, G
    Vetrani, A
    Rabitti, C
    CANCER LETTERS, 2004, 208 (02) : 227 - 234
  • [24] Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density
    Miralbell, R
    Tolnay, M
    Bieri, S
    Probst, A
    Sappino, AP
    Berchtold, W
    Pepper, MS
    Pizzolato, G
    JOURNAL OF NEURO-ONCOLOGY, 1999, 45 (02) : 103 - 110
  • [25] Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density
    Raymond Miralbell
    Markus Tolnay
    Sabine Bieri
    Alphonse Probst
    André-Pascal Sappino
    Willi Berchtold
    Michael S. Pepper
    Gianpaolo Pizzolato
    Journal of Neuro-Oncology, 1999, 45 : 103 - 110
  • [26] Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer
    Han, Hye Seung
    Park, Young-Mee
    Hwang, Tae Sook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (07) : 1108 - 1114
  • [27] Bax protein expression in colorectal cancer: Association with p53, bcl-2 and patterns of relapse
    Giatromanolaki, A
    Sivridis, E
    Stathopoulos, GP
    Fountzilas, G
    Kalofonos, HP
    Tsamandas, A
    Vrettou, E
    Scopa, C
    Polychronidis, A
    Simopoulos, K
    Koukourakis, MI
    ANTICANCER RESEARCH, 2001, 21 (1A) : 253 - 259
  • [28] P53, Bcl-2 expression and cell proliferation in benign breast lesions
    DiMartino, L
    Benini, E
    Faranda, A
    DeMontis, B
    Murenu, G
    Ferreli, A
    Daidone, MG
    Silvestrtni, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (06) : 1053 - 1057
  • [29] Cellular kinetics and expression of bcl-2 and p53 in ductal carcinoma of the breast
    Megha, T
    Ferrari, F
    Arcuri, F
    Lalinga, AV
    Lazzi, S
    Cardone, C
    Cevenini, G
    Leoncini, L
    Tosi, P
    ONCOLOGY REPORTS, 2000, 7 (03) : 473 - 478
  • [30] p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients
    Silvestrini, R
    Benini, E
    Veneroni, S
    Daidone, MG
    Tomasic, G
    Squicciarini, P
    Salvadori, B
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1604 - 1610